APLS vs CSGP · rev $781.4M vs P/E 484, rev $1.82B
Apellis Pharmaceuticals Inc (APLS) versus CoStar Group Inc (CSGP) — a side-by-side from cached financials, not a winner call.
Apellis Pharmaceuticals Inc (APLS) is a biotechnology company listed on US.
CoStar Group Inc (CSGP) is a real estate services company listed on US.
Latest reported APLS revenue for 2024-12-31 was $781.4M. Net income was -$197.9M. Revenue was up 97.0% from 2023-12-31 to 2024-12-31. APLS currently screens at market cap $2.29B.
Latest reported CSGP revenue for 2026-06-30 was $1.82B. Net income was $58.0M. CSGP currently screens at market cap $13.84B and trailing P/E 484.1.
APLS currently screens at market cap $2.29B. CSGP currently screens at market cap $13.84B and trailing P/E 484.1.
Not investment advice. Open the APLS and CSGP stock pages for the full models.
Not investment advice.